Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Colorectal Neoplasms 3Small Cell Lung Carcinoma 2Lung Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Spinocerebellar Degenerations 1Sarcoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Pancreatic Adenocarcinoma 1PD-L1-selected Solid Tumors 1Melanoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Chordoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Brain Neoplasms 1Advanced Solid Malignancies 1Advanced Rare Malignant Solid Neoplasm 1Advanced Liver Cancers 1

Interventions

Nivolumab 3Oxaliplatin 2Capecitabine 2trifluridine tipiracil drug combination 1sintilimab 1relatlimab 1regorafenib 1dabrafenib 1copanlisib 1atezolizumab 1Tiragolumab 1Leucovorin 1Immune Checkpoint Inhibitors 1Fulvestrant 1Fluorouracil 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Tiragolumab × 1 year × Clear all
NCT06784947 2025-10-02

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

University of Colorado, Denver

Phase 2 Active not recruiting
13 enrolled
Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡